Alios BioPharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2006-01-01
- Employees
- 51
- Market Cap
- -
First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1
- First Posted Date
- 2012-03-14
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- Alios Biopharma Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT01554085
- Locations
- 🇦🇺
CMAX, Adelaide, South Australia, Australia
🇦🇺QPharm, Brisbane, Queensland, Australia
🇳🇿Auckland Clinical Services, Auckland, New Zealand
© Copyright 2025. All Rights Reserved by MedPath